美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

卡波陶瓷

0.2970

0.0000

成交量：- -

成交額：- -

市值：872.03萬

市盈率：-0.10

高：0.2970

開：0.2970

低：0.2970

收：0.2970

52周最高：5.16

52周最低：0.2600

股本：2,936.12萬

流通股本：2,013.34萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-3.1183

每股收益(LYR):-2.7922

淨資產收益率：-27.50%

總資產收益率：-8.70%

市淨率：0.03

市盈率(LYR):-0.11

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

研發管線加速推進彰顯諾誠健華速度

证券市场红周刊

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CRR"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CRR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRR\",,,,,undefined,":{"symbol":"CRR","market":"US","secType":"STK","nameCN":"卡波陶瓷","latestPrice":0.297,"timestamp":1576875600000,"preClose":0.297,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":20133412,"shares":29361204,"eps":-3.118281,"marketStatus":"停牌","change":0,"latestTime":"12-20 16:00:00 EST","open":0.297,"high":0.297,"low":0.297,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.118281,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":830145600000,"exchange":"NYSE","adjPreClose":0.297,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRR\",,,,,undefined,":{"symbol":"CRR","floatShares":20133412,"roa":"-8.70%","roe":"-27.50%","lyrEps":-2.79216,"shares":29361204,"dividePrice":0,"high":0.297,"amplitude":0,"preClose":0.297,"low":0.297,"week52Low":0.26,"pbRate":"0.03","week52High":5.16,"institutionHeld":0.5736,"latestPrice":0.297,"eps":-3.118281,"divideRate":0,"volume":0,"delay":0,"ttmEps":-3.118281,"open":0.297,"prevYearClose":0.297},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CRR\",params:#limit:5,,,undefined,":[{"date":"2020-07-23","symbol":"CRR","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1595491200000,"name":null,"time":"盤前","dateTimestamp":1595476800000,"actualEps":null},{"date":"2020-04-23","symbol":"CRR","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1587628800000,"name":null,"time":"盤前","dateTimestamp":1587614400000,"actualEps":null},{"date":"2020-01-29","symbol":"CRR","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":-0.69,"defaultRemindTime":1580288400000,"name":null,"time":"盤前","dateTimestamp":1580274000000,"actualEps":null},{"market":"US","date":"2019-11-08","symbol":"CRR","fiscalQuarterEnding":"2019/09","expectedEps":-0.5,"name":null,"time":"盤前","type":"earning","dateTimestamp":1573189200000,"reportTimeType":"pre","actualEps":-0.58},{"date":"2019-07-25","symbol":"CRR","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-0.52,"defaultRemindTime":1564041600000,"name":null,"time":"盤前","dateTimestamp":1564027200000,"actualEps":-0.55}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CRR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CRR\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CRR\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2260619312","title":"研發管線加速推進 彰顯諾誠健華速度","url":"https://stock-news.laohu8.com/highlight/detail?id=2260619312","media":"证券市场红周刊","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2260619312?lang=zh_tw&edition=fundamental","pubTime":"2022-08-18 18:02","pubTimestamp":1660816929,"startTime":"0","endTime":"0","summary":"8月2日晚，证监会发布公告称，按法定程序同意诺诚健华医药有限公司在科创板首次公开发行股票注册，开启“A+H”征程。今年受大环境影响，生物医药行业面临较大挑战，但仍有一些优秀的创新药企保持良好发展，比如诺诚健华。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/money/fund/jjzl/2022-08-18/doc-imizirav8714221.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/money/fund/jjzl/2022-08-18/doc-imizirav8714221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["BK4515","MM","CDE","CSCO","BK4550","BK1574","BK4017","BK4020","BK4560","BK4579","BK4581","BK4534","BK1161","BK4525","CRR","09969","BK4533","BK4527"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CRR\",params:#limit:6,delay:false,,,undefined,":[]}}